Duke and {UNC} Chapel Hill researchers have used the drug Abilify as a scaffold to design a new class of antipsychotics that showed fewer side effects in mice. The researchers are negotiating a licensing deal for the compounds with an undisclosed pharma.
CITATION STYLE
Fulmer, T. (2011). Arrestin psychosis. Science-Business EXchange, 4(44), 1224–1224. https://doi.org/10.1038/scibx.2011.1224
Mendeley helps you to discover research relevant for your work.